| 1 |
[GO] |
2025―Jan―23 |
Neurological aspects of COVID-19 |
Marine M. Tanashyan, Polina I. Kuznetsova, Anton A. Raskurazhev |
| 2 |
[GO] |
2025―Jan―04 |
Complication of COVID-19: Mild Encephalopathy Syndrome with Reversible Splenial Lesion |
Tatiana V. Matveeva, Rustem T. Gaifutdinov, Dinara S. Kamalova, Gulnaz A. Fasakhova |
| 3 |
[GO] |
2024―Oct―03 |
Ischemic Stroke and Coronavirus Infection: Complications of Endovascular Thrombectomy |
Alexander I. Yakovlev, Igor A. Voznjouk, Tatiana V. Kharitonova, Alexander V. Savello, Mariia V. Prokhorova, Sergey V. Kolomentsev, Nadezhda А. Tsurikova, Margarita A. Romanova |
| 4 |
[GO] |
2024―Jul―08 |
Phenotypes of COVID-19-associated dysautonomia in patients requiring veno-venous extracorporeal membrane oxygenation |
German E. Savkov, Sergey S. Petrikov, Natalia V. Rybalko, Layla T. Khamidova, Olga Y. Markatuk, Kirill V. Kiselev, Dmitriy A. Lebedev, Yulia N. Vrabiy, Natavan E. Altschuler, Konstantin A. Popugaev |
| 5 |
[GO] |
2024―Apr―05 |
Ischemic Stroke and COVID-19 Infection: an Analysis of Treatment Outcomes in Patients who Underwent Endovascular Thrombectomy |
Alexander I. Yakovlev, Igor A. Voznyuk, Tatiana V. Kharitonova, Alexander V. Savello, Mariia V. Prokhorova, Sergey V. Kolomentsev, Nadezhda А. Tsurikova |
| 6 |
[GO] |
2024―Jan―05 |
Mood Disorders After COVID-19 |
Anna G. Mikheeva, Mariya P. Topuzova, Valeriya A. Malko, Ekaterina S. Zhilina, Arina A. Mikhailova, Daria I. Lagutina, Tatiana L. Karonova, Tatyana M. Alekseeva |
| 7 |
[GO] |
2023―Jun―21 |
Predictors of In-Hospital Mortality Among Patients with COVID-19 Related Stroke |
Airat R. Rakhmatullin, Mansur A. Kutlubaev, Amir T. Khayrullin |
| 8 |
[GO] |
2023―Jun―21 |
COVID-19 Features in Patients with Multiple Sclerosis: Main Approaches to Their Management, Treatment, and Vaccination |
Valeriya A. Malko, Gennady N. Bisaga, Mariya P. Topuzova, Ivan K. Ternovykh, Tatyana M. Alekseeva |
| 9 |
[GO] |
2022―Oct―10 |
Inflammation and endothelial toxicity: pathogenetic aspects of central nervous system damage due to novel coronavirus disease |
Maria V. Prokhorova, Aleksandr I. Yakovlev, Igor A. Voznyuk, Elena M. Morozova, Ekaterina A. Gogoleva, Lyudmila P. Pivovarova |
| 10 |
[GO] |
2022―Jun―30 |
Safety of pathogenetic therapy for multiple sclerosis during the COVID-19 pandemic |
Andrey M. Petrov, Marina V. Votintseva, Igor D. Stolyarov |
